scripClip clients safely delivered more than 12 million prescriptions this year and collectively saved more than $9 million. As the year comes to a close, we’re shining light on their achievements and their words of wisdom for fellow pharmacy leaders.
If technologies are available to keep people safer, do we have a moral obligation to implement them? Chew on that while you think about the several key areas where return on a will-call automation system investment adds up.
Consider what features would be helpful or even non-negotiable as you start to vet will-call automation technology options to establish or strengthen the integrity of your will-call processes. Here are 8 places to start.
Pharmacy will-call automation systems investments can vary. Brush up on what price to expect, what factors to weigh and how to assess long-term cost of ownership.
Pharmacies can lessen the impact of declining reimbursement and profit margins by broadening services, advocating for change and making wise technology investments.
How much are patient safety, inventory management, organization, staff satisfaction and customer loyalty worth to your pharmacy business?
Based on an ISMP study showing roughly 1 in every 1000 prescriptions are correctly dispensed but given to the wrong patient, we estimate scripClip helped avoid 35,000 such wrong-patient prescription-delivery errors in the last year.
University of Maryland Medical Center needed help to reduce the chances of busy pharmacy staff giving incorrect medication to patients. scripClip made a tremendous difference at the hospital system’s five outpatient pharmacies.
Thanks to collaborative development among Change Healthcare, InterLink AI, and a groundbreaking mutual customer, scripClip is easily added into the PMS functionality. With the simple click of a button on pharmacy workstation computers, personnel can check prescriptions into will-call and readily locate the right orders for the right patients at the point of sale.
“We provide better care by embracing technology,” said Prosperity Drug Company owner, John Pugh, PharmD, RPh. He illustrates that scripClip® was a worthwhile investment for him because it not only improves productivity in his pharmacy, but customers also see and feel the difference.
